Intravoxel incoherent motion (IVIM)-derived parameters in diffusion-weighted MRI: Associations with prognostic factors in invasive ductal carcinoma

Journal of Magnetic Resonance Imaging

Volumn 45, Issue 5, 2017, Pages 1394-1406

  Lee, Youn Joo ^a   Kim, Sung Hun ^b   Kang, Bong Joo ^b   Kang, Young Jee ^c   Yoo, Heesoo ^c   Yoo, Jaewan ^c   Lee, Jaeun ^c   Son, Yo Han ^d   Grimm, Robert ^e  

^a Daejeon St Mary's Hospital   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d SIEMENS Healthcare   (South Korea)

^e SIEMENS AG   (Germany)

Author keywords

diffusion weighted image; intravoxel incoherent motion; invasive ductal carcinoma; magnetic resonance imaging; prognostic factor

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER PROGNOSIS; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTRAVOXEL INCOHERENT MOTION; MAJOR CLINICAL STUDY; MEDICAL PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERFUSION FRACTION; PSEUDODIFFUSIVITY; RADIOLOGICAL PARAMETERS; RETROSPECTIVE STUDY; TISSUE DIFFUSIVITY; TUMOR VOLUME; BIOPSY; BREAST; BREAST TUMOR; DIAGNOSTIC IMAGING; FEMALE; IMAGE PROCESSING; MIDDLE AGED; MOTION; PAGET NIPPLE DISEASE; PATHOLOGY; PERFUSION; PROCEDURES; PROGNOSIS;

ADULT; AGED; BIOPSY; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MIDDLE AGED; MOTION; PERFUSION; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84998842224     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.25514     Document Type: Article

References (37)

1. Marini C, Iacconi C, Giannelli M, Cilotti A, Moretti M, Bartolozzi C. Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol 2007;17:2646–2655.
2. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002;16:172–178.
3. Partridge SC, Mullins CD, Kurland BF, et al. Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size. AJR Am J Roentgenol 2010;194:1664–1673.
4. Park MJ, Cha ES, Kang BJ, Ihn YK, Baik JH. The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol 2007;8:390–396.
5. Liu C, Liang C, Liu Z, Zhang S, Huang B. Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: comparison with conventional DWI. Eur J Radiol 2013;82:e782–e789.
6. Le Bihan D. IVIM method measures diffusion and perfusion. Diagnostic imaging 1990;12:133, 136.
7. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161:401–407.
8. Neil JJ, Bosch CS, Ackerman JJ. An evaluation of the sensitivity of the intravoxel incoherent motion (IVIM) method of blood flow measurement to changes in cerebral blood flow. Magn Reson Med 1994;32:60–65.
9. Toi, M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 1993;55:371–374.
10. Rosenkrantz AB, Padhani AR, Chenevert TL, et al. Body diffusion kurtosis imaging: Basic principles, applications, and considerations for clinical practice. J Magn Reson Imaging 2015;42:1190–1202.
11. Zhang Y-D, Wang Q, Wu C-J, et al. The histogram analysis of diffusion-weighted intravoxel incoherent motion (IVIM) imaging for differentiating the Gleason grade of prostate cancer. Eur Radiol 2015;25:994–1004.
12. Gaing B, Sigmund EE, Huang WC, et al. Subtype differentiation of renal tumors using voxel-based histogram analysis of intravoxel incoherent motion parameters. Invest Radiol 2015;50:144–152.
13. Kim Y, Ko K, Kim D, et al. Intravoxel incoherent motion diffusion-weighted MR imaging of breast cancer: association with histopathological features and subtypes. Br J Radiol 2016;89:1063.
14. Bokacheva L, Kaplan JB, Giri DD, et al. Intravoxel incoherent motion diffusion-weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma. J Magn Reson Imaging 2014;40:813–823.
15. Sigmund E, Cho G, Kim S, et al. Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer. Magn Reson Med 2011;65:1437–1447.
16. Iima M, Yano K, Kataoka M, et al. Quantitative non-Gaussian diffusion and intravoxel incoherent motion magnetic resonance imaging: differentiation of malignant and benign breast lesions. Invest Radiol 2015;50:205–211.
17. Cho GY, Moy L, Kim SG, et al. Evaluation of breast cancer using intravoxel incoherent motion (IVIM) histogram analysis: comparison with malignant status, histological subtype, and molecular prognostic factors. Eur Radiol 2016;26:2547–2558.
18. Suo S, Lin N, Wang H, et al. Intravoxel incoherent motion diffusion-weighted MR imaging of breast cancer at 3.0 Tesla: Comparison of different curve-fitting methods. J Magn Reson Imaging 2015;42:362–370.
19. Goldhirsch A, Wood W, Coates A, Gelber R, Thürlimann B, Senn H-J. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Ooncol 2011:MD.r304.
20. Makkat S, Luypaert R, Stadnik T, et al. Deconvolution-based dynamic contrast-enhanced mr imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor 2 status and clinicopathologic findings—preliminary results. Radiology 2008;249:471–482.
21. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype. Cancer 2007;109:1721–1728.
22. Szabó BK, Aspelin P, Wiberg MK, Tot T, Boné B. Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol 2003;13:2425–2435.
23. Lee HJ, Rha SY, Chung YE, et al. Tumor perfusion-related parameter of diffusion-weighted magnetic resonance imaging: Correlation with histological microvessel density. Magn Reson Med 2014;71:1554–1558.
24. Ludovini V, Sidoni A, Pistola L, et al. Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients. Breast Cancer Res Treat 2003;81:159–168.
25. Ding S-l, Sheu L-F, Yu J-C, et al. Expression of estrogen receptor-á and Ki67 in relation to pathological and molecular features in early-onset infiltrating ductal carcinoma. J Biomed Sci 2004;11:911–919.
26. Razek AAKA, Gaballa G, Denewer A, Nada N. Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors. NMR Biomed 2010;23:619–623.
27. Hasebe T, Sasaki S, Imoto S, Mukai K, Yokose T, Ochiai A. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study. Modern Pathol 2002;15:502–516.
28. Mesker WE, Junggeburt J, Szuhai K, et al. The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Anal Cell Pathol 2007;29:387–398.
29. De Kruijf EM, van Nes JG, van de Velde CJ, et al. Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients. Breast Cancer Res Treat 2011;125:687–696.
30. Ko ES, Han B-K, Kim RB, et al. Apparent diffusion coefficient in estrogen receptor-positive invasive ductal breast carcinoma: correlations with tumor-stroma ratio. Radiology 2013;271:30–37.
31. DeCarlo LT. On the meaning and use of kurtosis. Psychol Methods 1997;2:292.
32. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957;11:359–377.
33. Wiederer J, Pazahr S, Leo C, Nanz D, Boss A. Quantitative breast MRI: 2D histogram analysis of diffusion tensor parameters in normal tissue. Magn Reson Mater Phys Biol Med 2014;27:185–193.
34. Hatakenaka M, Soeda H, Yabuuchi H, et al. Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci 2008;7:23–29.
35. Black R, Prescott R, Bers K, Hawkins A, Stewart H, Forrest P. Tumour cellularity, oestrogen receptors and prognosis in breast cancer. Clin Oncol 1983;9:311–318.
36. Jarque F, Lluch A, Vera F, et al. Intratumoral variation of estrogen and progesterone receptors in breast cancer: relationship with histopathological characteristics of the tumor. Oncology 1990;47:9–13.
37. Nadrljanski M, Maksimovic R, Plesinac-Karapandzic V, Nikitovic M, Markovic-Vasiljkovic B, Milosevic Z. Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma. Eur J Radiol 2014;83:1363–1367.